Alsevalimab (Anti-B7-H4 / VTCN1)
Alsevalimab (Anti-B7-H4 / VTCN1) is a human monoclonal antibody targeting B7-H4. It has potential antineoplastic and immune checkpoint inhibitory activities. MW :144.74 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2597 |
| Sku # | A2597-1mg*25 |
| Pricing | 1mg*25, $2970.00 |